DK1435985T3 - Lægemiddel indeholdende aktiveret antithrombin III - Google Patents
Lægemiddel indeholdende aktiveret antithrombin IIIInfo
- Publication number
- DK1435985T3 DK1435985T3 DK01969710T DK01969710T DK1435985T3 DK 1435985 T3 DK1435985 T3 DK 1435985T3 DK 01969710 T DK01969710 T DK 01969710T DK 01969710 T DK01969710 T DK 01969710T DK 1435985 T3 DK1435985 T3 DK 1435985T3
- Authority
- DK
- Denmark
- Prior art keywords
- drug containing
- antithrombin iii
- containing activated
- activated antithrombin
- iii
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/55—Protease inhibitors
- A61K38/57—Protease inhibitors from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Oncology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Hematology (AREA)
- Communicable Diseases (AREA)
- Diabetes (AREA)
- Virology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Neurosurgery (AREA)
- AIDS & HIV (AREA)
- Neurology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Transplantation (AREA)
- Pulmonology (AREA)
- Dermatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10045047A DE10045047A1 (de) | 2000-09-12 | 2000-09-12 | Arzneimittel enthaltend aktiviertes Antithrombin III |
| PCT/EP2001/010541 WO2002022150A2 (de) | 2000-09-12 | 2001-09-12 | Arzneimittel enthaltend aktiviertes antithrombin iii |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1435985T3 true DK1435985T3 (da) | 2007-08-20 |
Family
ID=7655909
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK01969710T DK1435985T3 (da) | 2000-09-12 | 2001-09-12 | Lægemiddel indeholdende aktiveret antithrombin III |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US7388075B2 (da) |
| EP (1) | EP1435985B1 (da) |
| JP (1) | JP5517387B2 (da) |
| AP (1) | AP2049A (da) |
| AT (1) | ATE359085T1 (da) |
| AU (2) | AU2001289876B2 (da) |
| CY (1) | CY1106657T1 (da) |
| DE (2) | DE10045047A1 (da) |
| DK (1) | DK1435985T3 (da) |
| ES (1) | ES2283432T3 (da) |
| NZ (1) | NZ525292A (da) |
| PT (1) | PT1435985E (da) |
| WO (1) | WO2002022150A2 (da) |
| ZA (1) | ZA200302907B (da) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10051983A1 (de) * | 2000-10-20 | 2002-06-13 | Beate Kehrel | Inhibierung der pathogenen Wirkung oxidierter Proteine |
| JP4881535B2 (ja) * | 2000-10-20 | 2012-02-22 | ハンブルガー・シュティフトゥング・ツーア・フェルデルング・フォン・ヴィッセンシャフト・ウント・クルトゥーア | 酸化タンパク質、およびその生物活性、該活性メカニズム、該タンパク質の使用およびその阻害から誘導される治療的かつ診断的方法 |
| DE10102048A1 (de) * | 2001-01-17 | 2002-07-18 | Aventis Behring Gmbh | Antithrombin III gegen durch Angiogenese verursachte Krankheiten |
| JP2005527570A (ja) * | 2002-04-01 | 2005-09-15 | ジーティーシー バイオセラピューティックス インコーポレイテッド | 肺障害の治療 |
| ATE531427T1 (de) * | 2003-04-25 | 2011-11-15 | Hamburger Stiftung Zur Foerderung Von Wissenschaft Und Kultur | Bekämpfung von hi-virus infektionen mit durch hypochlorige säure oxidiertem menschlichem blutplasma |
| CA2664844A1 (en) * | 2006-10-06 | 2008-10-23 | Celtaxsys, Inc. | Chemorepulsion of cells |
| JP2010235447A (ja) * | 2007-07-30 | 2010-10-21 | Igaku Seibutsugaku Kenkyusho:Kk | 炎症性サイトカインの抑制剤 |
| DE102011003936A1 (de) | 2011-02-10 | 2012-08-16 | Oxprotect Gmbh | Verwendung von Proteinen/Peptiden, welche an GRP78 (BIP) binden, in Labormethoden zum Monitoring von Thrombozyten-Aggregationshemmern |
| CN105263319A (zh) | 2013-02-13 | 2016-01-20 | 法国化学与生物科技实验室 | 具有经修饰的糖基化的蛋白及其生产方法 |
| WO2017149391A1 (en) * | 2016-03-02 | 2017-09-08 | Laboratoire Francais Du Fractionnement Et Des Biotechnologies | The use of antithrombin for coating organs during transplantation |
| EP4311556A1 (en) * | 2022-07-28 | 2024-01-31 | Grifols Worldwide Operations Limited | Antithrombin in stroke |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2739050B2 (ja) | 1988-01-28 | 1998-04-08 | ヘキスト薬品工業株式会社 | 抗血液凝固剤 |
| DE4311580C1 (de) | 1993-04-12 | 1994-08-18 | Werner Prof Dr Med Reutter | Glycoproteine, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Mittel |
| JP3820607B2 (ja) * | 1995-11-10 | 2006-09-13 | 三菱ウェルファーマ株式会社 | アンチトロンビン−ｉｉｉの液状製剤およびその保存安定化方法 |
| US6686303B1 (en) * | 1998-11-13 | 2004-02-03 | Kimberly-Clark Worldwide, Inc. | Bicomponent nonwoven webs containing splittable thermoplastic filaments and a third component |
| DE19852729A1 (de) * | 1998-11-16 | 2000-05-18 | Werner Reutter | Rekombinante Glycoproteine, Verfahren zu ihrer Herstellung, sie enthaltende Arzneimittel und ihre Verwendung |
| EP1027894A3 (en) * | 1999-01-28 | 2001-01-24 | Aventis Behring Gesellschaft mit beschränkter Haftung | Pharmaceutical preparation for the treatment of inflammatory processes |
| EP1362127B1 (en) * | 2001-01-26 | 2007-11-07 | The General Hospital Corporation | Serpin drugs for treatment of hiv infection and method of use thereof |
-
2000
- 2000-09-12 DE DE10045047A patent/DE10045047A1/de not_active Ceased
-
2001
- 2001-09-12 PT PT01969710T patent/PT1435985E/pt unknown
- 2001-09-12 DK DK01969710T patent/DK1435985T3/da active
- 2001-09-12 US US10/380,274 patent/US7388075B2/en not_active Expired - Fee Related
- 2001-09-12 JP JP2002526400A patent/JP5517387B2/ja not_active Expired - Fee Related
- 2001-09-12 AT AT01969710T patent/ATE359085T1/de active
- 2001-09-12 WO PCT/EP2001/010541 patent/WO2002022150A2/de active IP Right Grant
- 2001-09-12 AU AU2001289876A patent/AU2001289876B2/en not_active Ceased
- 2001-09-12 AU AU8987601A patent/AU8987601A/xx active Pending
- 2001-09-12 ES ES01969710T patent/ES2283432T3/es not_active Expired - Lifetime
- 2001-09-12 NZ NZ525292A patent/NZ525292A/en not_active IP Right Cessation
- 2001-09-12 DE DE50112350T patent/DE50112350D1/de not_active Expired - Lifetime
- 2001-09-12 AP APAP/P/2003/002783A patent/AP2049A/en active
- 2001-09-12 EP EP01969710A patent/EP1435985B1/de not_active Expired - Lifetime
-
2003
- 2003-04-14 ZA ZA200302907A patent/ZA200302907B/en unknown
-
2007
- 2007-06-14 CY CY20071100791T patent/CY1106657T1/el unknown
-
2008
- 2008-06-11 US US12/137,239 patent/US8114840B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| US8114840B2 (en) | 2012-02-14 |
| ES2283432T3 (es) | 2007-11-01 |
| US20040029799A1 (en) | 2004-02-12 |
| WO2002022150A3 (de) | 2004-05-06 |
| AP2049A (en) | 2009-09-25 |
| AU2001289876B2 (en) | 2006-09-07 |
| NZ525292A (en) | 2005-08-26 |
| JP2004518625A (ja) | 2004-06-24 |
| EP1435985A2 (de) | 2004-07-14 |
| CY1106657T1 (el) | 2012-01-25 |
| WO2002022150A2 (de) | 2002-03-21 |
| US7388075B2 (en) | 2008-06-17 |
| ATE359085T1 (de) | 2007-05-15 |
| AU8987601A (en) | 2002-03-26 |
| EP1435985B1 (de) | 2007-04-11 |
| PT1435985E (pt) | 2007-07-11 |
| AP2003002783A0 (en) | 2003-06-30 |
| JP5517387B2 (ja) | 2014-06-11 |
| ZA200302907B (en) | 2003-09-15 |
| DE10045047A1 (de) | 2002-03-21 |
| US20090036360A1 (en) | 2009-02-05 |
| DE50112350D1 (de) | 2007-05-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE311915T1 (de) | Medikamentenspender | |
| IS6686A (is) | Hýdrógel-drifið lyfjaskömmtunarform | |
| DK1524266T3 (da) | Farmaceutisk sammensætning | |
| DE60126272D1 (de) | Feststellkatheter | |
| DE50115672D1 (de) | Halterung | |
| NO20003967D0 (no) | Farmasøytiske preparater | |
| ATE392890T1 (de) | Hydrogel-gesteuerte dosierungsform | |
| DZ3409A1 (fr) | Association therapeuthique | |
| AT7729U3 (de) | Pharmazeutische zusammensetzungen enthaltend amlodipinmaleat | |
| DE60113214D1 (de) | Plattierungsbadanalyse | |
| MXPA03001425A (es) | Compuestos farmaceuticos. | |
| DE60131992D1 (de) | Pfropfcopolymere enthaltende klebstoffe | |
| DE60032946D1 (de) | Katheter | |
| ATE366128T1 (de) | Pharmazeutische zusammensetzung | |
| DK1435985T3 (da) | Lægemiddel indeholdende aktiveret antithrombin III | |
| DE10196460T1 (de) | Selbstzerstör-Spritze | |
| DE50113112D1 (de) | Schaltungsanordnung | |
| DE60134742D1 (de) | Selbstentfaltbare katheteranordung | |
| FR2805803B1 (fr) | Monte-materiaux | |
| FI4651U1 (fi) | Kaivo | |
| FI20001398A (fi) | Kaivo | |
| DE50115426D1 (de) | Schaltungsanordnung | |
| SE0004584D0 (sv) | Leveransenhet | |
| SE0001240D0 (sv) | Injektionsspruta | |
| UA4638S (uk) | Шприц |